93 OZ Pill - red & white capsule/oblong
Generic Name: arimoclomol
Pill with imprint 93 OZ is Red & White, Capsule/Oblong and has been identified as Miplyffa 93 mg. It is supplied by Zevra Therapeutics, Inc.
Miplyffa is used in the treatment of Niemann-Pick Disease and belongs to the drug class miscellaneous metabolic agents. Miplyffa 93 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 OZ
Miplyffa
- Generic Name
- arimoclomol
- Imprint
- 93 OZ
- Strength
- 93 mg
- Color
- Red & White (white opaque body with red opaque cap)
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zevra Therapeutics, Inc.
- National Drug Code (NDC)
- 72542-0124
See also:
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Kuvan
Kuvan is used to help the body activate the enzyme needed to control blood levels of phenylalanine ...
More about Miplyffa (arimoclomol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.